A clinical case of Clostridium difficile colitis


DOI: https://dx.doi.org/10.18565/epidem.2020.10.1.80-5

Kupchenko A.N., Mogileva A.A., Ponezheva Zh.B.

1) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Customer Rights Protection and Human Well-Being, Moscow, Russia; 2) Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department, Moscow, Russia
Currently, there are more and more cases of the development of antibiotic-associated diarrhea in patients, which means at least three unformed stools for two or more consecutive days while taking antibiotics. The paper presents the clinical features, diagnosis, and differential diagnosis of antibiotic-associated infection and describes a clinical case of the development of enterocolitis caused by Cl. difficile toxins A and B in an immunosuppressed patient using antibiotics.

Literature



  1. Ивашкин В.Т., Ющук Н.Д., Маев И.В., Лапина Т.Л., Полуэктова Е.А., Шифрин О.С., Тертычный А.С., Трухманов А.С., Шептулин А.А., Баранская Е.К., Ляшенко О.С., Ивашкин К.В. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению Clostridium difficile-ассоциированной болезни. Рос. журн. гастроэнтерол. гепатол. колопроктол. 2016; 26(5): 56–65.

    Ivashkin V.T., Yushchuk N.D., Mayev I.V., Lapina T.L., Poluektova E.A., Shifrin O.S., Tertychnyi A.S., Trukhmanov A.S., Sheptulin A.A., Baranskaya E.K., Lyashenko O.S., Ivashkin K.V. [Recommendations of the Russian gastroenterological Association for the diagnosis and treatment of Clostridium difficile-associated disease]. Rossiyskiy zhurnal gastroenterologii. gepatologii i koloproktologii 2016; 26(5): 56–65. (In Russ.).



  2. Steele J., Chen K., Sun X., Wang H., Tzipori S., Feng. H. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J. Infect. Dis. 2012; 205: 384–91. DOI: 10.1093/infdis/jir748.

  3. Davies K.A., Longshaw C.M., Davis G.L., Bouza E., Bouza E., Barbut F., Barna Z. et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point- prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect. Dis. 2014; 14(12): 1208–19. DOI: 10.1016/S1473-3099(14)70991-0.

  4. Goudarzi M., Seyedjavadi S.S., Goudarzi H., Mehdizadeh Aghdam E., Nazeri S. Clostridium difficile infection: Epidemiology, pathogenesis, risk factors, and therapeutic options. Scientifica 2014; 2014: Article ID 916826. DOI: 10.1155/2014/916826

  5. Furuya-Kanamori L., Marquess J., Yakob L., Riley T.V., Paterson D.L., Foster N.F., Huber C.A., Clements A.C. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications BMC Infect. Dis. 2015; 15: 516. DOI: 10.1186/s12879-015-1258-4.

  6. Surawicz С.M., Brandt L.J., Binion D.G., Ananthakrishnan A.N., Curry S.R., Gilligan P.H., McFarland L.V., Mellow M., Zuckerbraun B.S. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections Am. J. Gastroenterol. 2013; 108(4): 478–98. DOI: 10.1038/ajg.2013.4

  7. Paredes-Sabja D., Shen A., Sorg J.A. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol. 2014; 22: 406–16. DOI: 10.1016/j.tim.2014.04.003 ·

  8. Николаева И.В., Шестакова И.В., Муртазина Г.Х. Современные стратеги диагностики и лечения Clostridium difficile-инфекции (обзор литературы). Acta Biomedica Scientifica 2018; 3(1): 34–42. https://doi.org/10.29413/ABS. 2018-3.1.5

    Nikolaeva I.V., Shestakova I.V., Murtazina G.K. Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review). Acta Biomedica Scientifica 2018; 3(1): 34–42. (In Russ.). https://doi.org/10.29413/ ABS.2018-3.1.5



  9. Черненькая Т.В. Псевдомембранозный колит: диагностика, лечение и профилактика (обзор литературы). Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь» 2016; (1): 33–9.

    Chyornenkaya T.V. [Pseudomembranous colitis: diagnosis, treatment and prevention]. Sklifosovsky Journal «Emergency Medical Care» 2016; (1): 33–9. (In Russ.).



  10. Keller J.M., Surawicz C.M. Clostridium difficile infection in Еldery. Clin. Geriatr. Med. 2014; 30: 79–93. DOI: 10.1016/j.cger.2013.10.008

  11. Furuya-Kanamori L., Stone J.C., Clark J., McKenzie S.J., Yakob L., Paterson D.L. , Riley T.V., Doi S.A., Clements A.C. Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: A systematic review and meta-analysis. Infect. Control Hosp. Epidemiol. 2015; 36(2): 132–41. DOI: 10.1017/ice.2014.39.

  12. Sartelli M., Malangoni M.A., Abu-Zidan F.M., Griffiths E.A., di Bella S., McFarland L.V. et al. WSES guidelines for management of Clostridium difficile infection in surgical patients. World J. Emerg. Surg. 2015; 10: 38. DOI: 10.1186/s13017-015-0033-6.

  13. Deshpande A., Pant C., Pasupuleti V., Rolston D.D., Jain A., Deshpande N., Thota P., Sferra T.J., Hernandez A.V. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(3): 225–33. DOI: 10.1016/j.cgh.2011.09.030.

  14. Лобзин Ю.В., Захаренко С.М., Иванов Г.А. Современные представления об инфекции Clostridium difficile. Клиническая микробиология и антимикробная терапия 2002; 4(3): 200–32.

    Lobzin Yu.V., Zakharenko S.M., Ivanov G.A. [Current understanding of Clostridium difficile infection]. Klinicheskaya mikrobiologiya i antimikrobnaya terapiya 2002; 4(3): 200–32. (In Russ.).



  15. Crobach M.J., Dekkers O.M., Wilcox M.H., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin. Microbiol. Infect. 2009; 15(12): 1053–66. DOI: 10.1111/j.1469-0691.2009.03098.x.

  16. Bartlett J.G., Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin. Infect. Dis. 2008; 46(Suppl. 1): 12–8. DOI: 10.1086/521863.

  17. Ивашкин В.Т., Шелыгин Ю.А., Абдулганиева Д.И., Абдулхаков Р.А., Алексеева С.И., Баранов­ский  А.Ю.,
Головенко О.В., Григорьев Н.В., Лапина Т.Л., Маев И.В., Москалев А.И., Низов А.И., Николаева Н.Н., Осипенко М.Ф., Павленко В.В., Парфенов А.И., Полуэктова Е.А., Румянцев В.Г., Тимербулатов В.М., Тертычный А.С., Ткачев А.В., Трухманов А.С., Халиф И.Л., Хубезов Д.А., Чашкова Е.Ю., Шифрин О.С. Рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению взрослых больных язвенным колитом. Рос. журн. гастроэнтерол., гепатол. колопроктол. 2015; 25(1): 48–65.

    Ivashkin V.T., Shelygin Yu.A., Abdulganiyeva D.I., Abdulkhakov R.A., Alekseyeva S.I., Baranovskii A.Yu., Golovenko O.V., Grigoryev N.V., Lapina T.L., Mayev I.V., Moskalev A.I., Nizov A.I., Nikolayeva N.N., Osipenko M.F., Pavlenko V.V., Parfenov A.I., Poluektova E.A., Rumyantsev V.G., Timerbulatov V.M., Tertychnyi A.S., Tkachev A.V., Trukhmanov A.S., Khalif I.L., Khubezov D.A., Chashkova E.Yu., Shifrin O.S. [Recommendations of the Russian gastroenterological Association and the Association of coloproctologists of Russia for the diagnosis and treatment of adult patients with ulcerative colitis]. Rossiyskiy zhurnal gastroenterologii. gepatologii i koloproktologii 2015; 25(1): 48–65. (In Russ.).



  18. Александрова Л.М., Чиссов В.И., Давыдов М.И. Онкология. Национальное руководство. М.: ГЭОТАР-Медиа, 2013. 576 с.

    Aleksandrova L.M., Chissov V.I., Davydov M.I. [Oncology. National leadership ]. Moscow: GEOTAR-Media, 2013. 576 p. (In Russ.).



  19. Ющук Н.Д., Венгеров Ю.Я. (ред.). Инфекционные болезни. Национальное руководство. М. : ГЭОТАР-Медиа, 2018. 1104 с.

    Yushchuk N.D., Vengerov Yu.Ya. (eds.). [Infectious disease. National leadership]. Moscow: GEOTAR-Media, 2018. 1104 p. (In Russ.).




About the Autors


Aleksandra N. Kupchenko, Junior Researcher, Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Customer Rights Protection and Human Well-Being; Infectiologist, Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department, Moscow, Russia; e-mail: alyaspid@gmail.com; ORCID: http://orcid.org/0000-0002-2893-0854
Aleksandra A. Mogileva, Resident Physician, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Customer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: al.mogileva@gmail.com
Zhanna B. Ponezheva, MD; Head, Clinical Department of Infectious Diseases, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; е-mail: doktorim@mail.ru; ORCID 0000-0002-6539-4878


Similar Articles


Бионика Медиа